Norethindrone Acetate Patch

Product Overview

Development Status: Active Development

Target: Female

Mode: Hormonal

Delivery Type: Transdermal

Duration Type: Short-acting

Description: Norethindrone acetate transdermal delivery system (patch).

Updated date: May 30, 2018

Vertical Tabs

Status

Project Phase: Post-development

Project Stage: Regulatory

Status Details:
  • Phase III completed in 2012. NDA filed with US FDA in 2013.

Download Product Report